Logo - springer
Slogan - springer

Medicine - Oncology & Hematology | Late Sequelae in Oncology

Late Sequelae in Oncology

With contributions by numerous experts

Dunst, Jürgen, Sauer, Rolf (Eds.)

Softcover reprint of the original 1st ed. 1995, XI, 300 pp. 80 figs., 104 tabs.

Available Formats:

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.


(net) price for USA

ISBN 978-3-642-46794-3

digitally watermarked, no DRM

Included Format: PDF

download immediately after purchase

learn more about Springer eBooks

add to marked items


Softcover (also known as softback) version.

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.


(net) price for USA

ISBN 978-3-642-46796-7

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days

add to marked items

  • About this book

Increasing survival figures and the use of more intense combined treatment regimens in modern oncology have raised the problem of late therapeutic sequelae in long-term survivors after cancer. Recent scientific approaches to late sequelae concentrate on the evaluation of subclinical changes with sophisticated functional measurements and experimental investigation of the underlying pathophysiological mechanisms. The objective of the book is to bring together these recent clinical and experimental data from different medical disciplines to give an overview of the most relevant problems of late sequelae. In clinical practice the book may help regarding estimation of risks, selection of diagnostic methods, and estimation of the prognosis of late sequelae.

Content Level » Research

Keywords » Chemotherapie - Krebsbehandlung - Oncology - Onkologie - Radiotherapie - Spätfolgen - cancer - cancer treatment - chemotherapy - late sequelae - radiotherapy

Related subjects » Oncology & Hematology - Radiology

Table of contents 

1 Individual Variation of Radio- and Chemosensitivity.- 1.1 Impact of Endogenous and Exogenous Factors on Radiation Sequelae.- 1.2 Endogenous and Exogenous Factors Modifying Chemosensitivity to Cytostatic Drugs.- 2 Neurotoxicity.- 2.1 Radiation-Induced Injury of the Central Nervous System.- 2.2 Cytostatic-Induced Central Nervous System Abnormalities.- 2.3 Radiation Myelopathy.- 2.4 Acute and Late Toxicity on Peripheral Nerves After Radiotherapy.- 2.5 Acute and Late Toxicity on Peripheral Nerves After Chemotherapy — A Review.- 2.6 Endocrine Dysfunction After Brain Tumor Therapy in Children.- 2.7 Endocrine Dysfunction in Adults After Radiotherapy for Pituitary Adenomas and Suprasellar Tumors.- 2.8 Late Sequelae Affecting the Ear.- 2.9 Ototoxicity in Pediatric Oncology.- 3 Skin and Mucosal Toxicity.- 3.1 Biological Basis for Skin and Mucosal Toxicity.- 3.2 Radiation-Induced Fibrosis: Experimental Studies.- 3.3 Lymphedema of the Arm After Treatment of Breast Cancer.- 3.4 Skin and Mucosal Damage After Radiotherapy for Head and Neck Tumors.- 3.5 Mucosal Toxicity After Radiochemotherapy.- 3.6 Complications of the Small Intestine and the Pancreas After Intraoperative Radiotherapy.- 3.7 Skin Toxicity.- 4 Lung Toxicity.- 4.1 Radiation Pneumopathy — Experimental and Clinical Data.- 4.2 Lung Toxicity of Chemotherapeutic Agents.- 4.3 Differential Diagnosis of Treatment Sequelae in the Lung.- 5 Cardiotoxicity.- 5.1 Evaluation of Late Cardiotoxicity by Pulsed Doppler Echocardiography in Patients Treated for Hodgkin’s Disease.- 5.2 Anthracycline-Induced Cardiotoxicity in Children: Pathophysiology and Prevention.- 5.3 Radiation-Induced Cardiotoxicity: Experimental Data.- 5.4 Cardiotoxicity After Megavoltage Irradiation and Chemotherapy for Hodgkin’s Disease with Special Emphasis on Coronary Heart Disease Mortality — The Freiburg Experience 1940-1992.- 5.5 Cardiac Morbidity and Mortality Followig Radiotherapy.- 6 Nephrotoxicity.- 6.1 Nephrotoxicity of Ifosfamide in Children.- 6.2 Radiation Nephritis.- 7 Gonadal Toxicity.- 7.1 Long-Term Gonadal Dysfunction and Its Impact on Bone Mineralization in Patients Following COPP/ABVD Chemotherapy for Hodgkin’s Disease.- 7.2 Gonadal Dysfunction After Radiotherapy.- 8 Disturbances of Sceletal Growth.- 8.1 Dose-Time Considerations for Skeletal Growth Disturbances After Radiotherapy.- 8.2 Disturbances in Growth of Bone, Muscle, and Fat Tissue Following Irradiation in Childhood.- 8.3 Growth Failure Secondary to Radiotherapy of Brain Tumors in Childhood.- 9 Cancerogenesis.- 9.1 Experiments on the Carcinogenic Potential of Antineoplastic Agents.- 9.2 Secondary Malignancies Following Cytotoxic Chemotherapy.- 9.3 Secondary Malignancies After Radiotherapy.- List of Contributors.

Popular Content within this publication 



Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Oncology.